Clinical Trials Directory

Trials / Completed

CompletedNCT04387838

Study of the SARS-COV-2 (COVID-19) Serological Profile of an Army Training Hospital Staff

Status
Completed
Phase
Study type
Observational
Enrollment
845 (actual)
Sponsor
Direction Centrale du Service de Santé des Armées · Academic / Other
Sex
All
Age
18 Years – 62 Years
Healthy volunteers
Accepted

Summary

Emerging in China in December 2019, Covid-19, whose pathogen is SARS-Cov-2, was declared a global pandemic in March 2020. The clinical presentation is highly variable, ranging from asymptomatic forms to acute respiratory distress and even death. Transmission occurs through droplets, with a R0 of approximately 3. Rapidly, population protection measures were put in place by governments, including the confinement of all persons whose functions were not considered essential and the closure of educational institutions. Health care institutions are places at risk of Covid-19 transmission and hospital staff are particularly exposed, either through direct contact with patients, contact with exposed persons or through the environment. In order to protect personnel, hygiene measures were immediately recalled and reinforced. This study is aimed at evaluating the incidence rate of anti-SARS-Cov2 seroconversion over 2 months among hospital staff, without any supposed anti-Covid treatment 19.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTAnti-SARS-CoV2 SerologyA blood sample is collected by venipuncture at Day 0, Day 30 and Day 60. The anti-SARS-CoV2 serological status is measured by automated microplate ELISA technique on the EVOLIS analyzer (Biorad®), using reagent kits from EUROIMMUN France.
OTHERQuestionnaireData concerning personal exposure factors are collected in a questionnaire: * Socio-demographic factors: sex, age * Professional factors: Employment (type, pace, reception, service, care practices), wearing of personal protective equipment (type of equipment, frequency of use) and type of hospital * Non-professional factors: Contact with infected individuals, carrying of professional equipment and compliance with barrier measures

Timeline

Start date
2020-05-14
Primary completion
2020-08-15
Completion
2020-08-15
First posted
2020-05-14
Last updated
2021-03-09

Locations

2 sites across 1 country: France

Source: ClinicalTrials.gov record NCT04387838. Inclusion in this directory is not an endorsement.